Immuneering IMRX
NASDAQ IMRX
$4.82 -0.22 (-4.37%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immuneering (IMRX) Gross Margin Growth (1y) (2021 - 2022)

Analysis

Immuneering (IMRX) Gross Margin Growth (1y) (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -93.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -91.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 210.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1,966.00
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 228.00
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -475.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1,034.00
10 Immuneering 313.13 Mn 313.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 10,877.00
Sep 30, 2022 -496.00
Jun 30, 2022 -250.00
Mar 31, 2022 523.00
Dec 31, 2021 -3,762.00
Sep 30, 2021 71.00
Jun 30, 2021 103.00